Buys
Open market- Shares
- Avg price
- Total value
David Kirske - Chief Financial Officer at X4 Pharmaceuticals, Inc
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- XFOR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for David Kirske in X4 Pharmaceuticals, Inc
Sells
Open market- Shares
- -25,504
- Avg price
- $4.28
- Total value
- -$109,249
Net
Past year- Shares
- -25,504
- Share %
- -100%
- Total value
- -$109,249
Reported holdings for David Kirske in X4 Pharmaceuticals, Inc
Form 4 holding
Chief Financial Officer
X4 Pharmaceuticals, Inc
- Security class
- Common Stock
- Shares / value
- 167,750
- Estimated value
- $715,302
- Report date
- 30 Jun 2026
- Price
- $4.26
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
X4 Pharmaceuticals, Inc
- Security class
- Stock Option (right to buy)
- Shares / value
- 1,552,769
- Estimated value
- Report date
- 29 Oct 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for David Kirske in X4 Pharmaceuticals, Inc
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.